The Board of Directors of the Company at its meeting held today May 30 2022 has inter alia based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the members in the forthcoming Annual General Meeting has approved the re-appointment of Mr. P. Sarath Chandra Reddy as Whole-time Director of the Company for a period of 3 years with effect from June 1 2022. He is related to Mr. P.V. Ramprasad Reddy Director of the Company.
Aurobindo Pharma: Re-Appointment Of Executive Director.
May 30, 2022
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month